David E. Amacher

74 papers receiving 2.1k citations

Peers

David E. Amacher
Comparison fields: 5 of 121
  • Pharmacology 614
  • Chemical Health and Safety 30
  • Cancer Research 577
  • Hepatology 171
  • Health, Toxicology and Mutagenesis 276
Replace Jiri Aubrecht with:
Jiri Aubrecht United States
Gregory L. Kedderis United States
Joost H.M. van Delft Netherlands
Jon C. Mirsalis United States
Georges de Sousa France
Dietmar Utesch Germany
Patrick D. Lilly United States
R. Schoental United Kingdom
Makoto Asamoto Japan
D.S.R. Sarma Canada
David E. Amacher relative to Jiri Aubrecht United States Jiri Aubrecht's profile →
Citations per field
00.5×1.5×2.3×
Jiri Aubrecht · 1×
Citations per year

Countries citing papers authored by David E. Amacher

Since Specialization
Citations

This map shows the geographic impact of David E. Amacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Amacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Amacher more than expected).

Fields of papers citing papers by David E. Amacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Amacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Amacher. The network helps show where David E. Amacher may publish in the future.

Co-authors

The 25 scholars most cited alongside David E. Amacher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Amacher Line = papers co-authored together David E. Amacher links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1998198
2 2002109
3 1998104
4 1980101
5 198098
6 197987
7 201483
8 197781
9 201378
10 200577
11 200572
12 201071
13 199170
14 200668
15 199754
16 197750
17 201347
18 201246
19 200845
20 199744

About David E. Amacher

David E. Amacher is a scholar working on Molecular Biology, Pharmacology, Cancer Research, Oncology and Health, Toxicology and Mutagenesis, having authored 76 papers that have together received 2.3k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (21 papers), Pharmacogenetics and Drug Metabolism (18 papers), Drug-Induced Hepatotoxicity and Protection (18 papers), DNA Repair Mechanisms (16 papers), Drug Transport and Resistance Mechanisms (13 papers), Liver Disease Diagnosis and Treatment (8 papers), Liver physiology and pathology (6 papers) and Effects and risks of endocrine disrupting chemicals (6 papers). The work is most often cited by research in Pharmacology (614 citations), Chemical Health and Safety (30 citations), Cancer Research (577 citations), Hepatology (171 citations) and Health, Toxicology and Mutagenesis (276 citations). David E. Amacher has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Simone C. Paillet, Shelli Schomaker, Gail N. Turner, Michael W. Lieberman, Verne A. Ray, John E. Burkhardt, Naga Chalasani, John A. Elliott, Jiri Aubrecht and James A. Retsema. Their work appears in journals such as Toxicology and Applied Pharmacology, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Expert Opinion on Drug Metabolism & Toxicology, Food and Chemical Toxicology and Toxicologic Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact